Extended capability for Oral Liquids and Semi-sold dosage forms in our Phase 1 facility
KNOW MOREGround breaking for our Phase 2 expansion in the Manufacturing facility completed on October 9th, 2021
KNOW MOREContract Pharmaceutical R&D facility is fully functional wrt to Oral Solid Dosage forms and Injectable.
KNOW MOREGround Breaking for our Phase 1 Manufacturing facility completed on Oct 25th,2020.
KNOW MOREAxxelent Pharma Science receives Permanent Registration Number (PPM/OCT-2020/00044) from Central Bureau of Narcotics,India.
KNOW MOREHeadquartered in Chennai, India, Axxelent is focused on Contract Development of Oral Solid Dosage, Injectables, Ophthalmic, Oral Liquids and Topicals and Manufacturing of Oral Solid Dosage, Oral Liquids and Topicals (Block-1) and Injectables & Ophthalmic (Block-2), for markets across the world including Europe and North America.
CIN : U24110TN2019PTC131943
Axxelent Pharma Science Pvt. Ltd., Module No.1, 10th Floor
A Block, IIT Madras Research Park, Kanagam Road, Taramani, Chennai-600113.
Tamil Nadu, India.
Call Us On : +91-44-61727900
Email Us : info@axxelent.com
SEZ UNIT No.910, Portia Road, Sri City, Tirupati District,
Andhra Pradesh, 517646.
Andhra Pradesh, India.
Call Us On : +91 8576 691100
Email Us : info@axxelent.com
3 Jagadeeswaran Street
T.Nagar
Chennai-600017, India.
Call Us On : 044-69127900
Email Us : info@axxelent.com
Expansion of Phase 2 Manufacturing for Small Volume Parenteral“Axxelent R&D unit received Recognition letter & Registration Certificate from DSIR, Ministry of Science and Technology, Govt. of India”